Lunai Bioworks (LNAI) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.68, -17.63% vs the prior close of $0.83.
- Volume 79.41K shares, 1.3x its 50-day average.
- New SEC filings: SCHEDULE 13D/A (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
LNAI slides 17.6% to $0.68, a 52-week low, 5 down days in a row. Closed at $0.68, -17.63% vs the prior close of $0.83. Day range $0.66–$0.81, opened at $0.81.
LNAI daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — LNAI slides 17.6% to $0.68, a 52-week low, 5 down days in a row
- Closed at $0.68, -17.63% vs the prior close of $0.83. Day range $0.66–$0.81, opened at $0.81.
- Volume was 79.41K shares, 1.3x its 50-day average of 62.85K.
- Price is -65.2% vs its 50-day average ($1.95) and -78.9% vs its 200-day average ($3.23).
- 52-week range $0.66–$13.28; today's close sits at 0% of that range, 94.9% below the 52-week high.
- That makes 5 straight losses.
Oct 15, 2026 — LNAI slides 7.4% to $0.83, a 52-week low, 4 down days in a row
- Closed at $0.83, -7.40% vs the prior close of $0.89. Day range $0.82–$0.92, opened at $0.87.
- Volume was 37.80K shares, 0.6x its 50-day average of 64.16K — lighter than usual.
- Price is -58.5% vs its 50-day average ($1.99) and -74.7% vs its 200-day average ($3.26).
- 52-week range $0.82–$13.28; today's close sits at 0% of that range, 93.8% below the 52-week high.
- That makes 4 straight losses.
Oct 14, 2026 — LNAI slides 13.4% to $0.89, a 52-week low, 3 down days in a row
- Closed at $0.89, -13.40% vs the prior close of $1.03. Day range $0.89–$1.00, opened at $1.00.
- Volume was 69.40K shares, 0.9x its 50-day average of 79.67K.
- Price is -55.9% vs its 50-day average ($2.02) and -72.9% vs its 200-day average ($3.30).
- 52-week range $0.88–$13.28; today's close sits at 0% of that range, 93.3% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — LNAI slides 7.2% to $1.03, a 52-week low
- Closed at $1.03, -7.21% vs the prior close of $1.11. Day range $1.01–$1.09, opened at $1.09.
- Volume was 46.00K shares, 0.2x its 50-day average of 240.81K — lighter than usual.
- Price is -49.9% vs its 50-day average ($2.06) and -69.1% vs its 200-day average ($3.33).
- 52-week range $0.88–$13.28; today's close sits at 1% of that range, 92.2% below the 52-week high.
- SEC filings that day: 10-K.
Oct 12, 2026 — LNAI slides 9.8% to $1.11
- Closed at $1.11, -9.76% vs the prior close of $1.23. Day range $1.05–$1.29, opened at $1.29.
- Volume was 97.20K shares, 0.4x its 50-day average of 239.40K — lighter than usual.
- Price is -46.7% vs its 50-day average ($2.08) and -67.0% vs its 200-day average ($3.37).
- 52-week range $0.88–$13.28; today's close sits at 2% of that range, 91.6% below the 52-week high.
Oct 9, 2026 — LNAI jumps 9.8% to $1.23 on 3.8x normal volume
- Closed at $1.23, +9.82% vs the prior close of $1.12. Day range $0.88–$1.68, opened at $1.17.
- Volume was 853.30K shares, 3.8x its 50-day average of 222.80K — unusually heavy trading.
- Price is -41.4% vs its 50-day average ($2.10) and -63.8% vs its 200-day average ($3.40).
- 52-week range $0.88–$13.28; today's close sits at 3% of that range, 90.7% below the 52-week high.
- SEC filings that day: 8-K.
Oct 8, 2026 — LNAI rises 2.8% to $1.12
- Closed at $1.12, +2.75% vs the prior close of $1.09. Day range $1.10–$1.15, opened at $1.14.
- Volume was 14.80K shares, 0.1x its 50-day average of 222.80K — lighter than usual.
- Price is -47.0% vs its 50-day average ($2.11) and -67.4% vs its 200-day average ($3.43).
- 52-week range $1.08–$13.28; today's close sits at 0% of that range, 91.6% below the 52-week high.
Oct 7, 2026 — LNAI slides 3.5% to $1.09, a 52-week low, 13 down days in a row
- Closed at $1.09, -3.54% vs the prior close of $1.13. Day range $1.08–$1.19, opened at $1.19.
- Volume was 20.00K shares, 0.1x its 50-day average of 222.64K — lighter than usual.
- Price is -48.9% vs its 50-day average ($2.13) and -68.6% vs its 200-day average ($3.47).
- 52-week range $1.08–$13.28; today's close sits at 0% of that range, 91.8% below the 52-week high.
- That makes 13 straight losses.
Oct 6, 2026 — LNAI dips 0.9% to $1.13, a 52-week low, 12 down days in a row
- Closed at $1.13, -0.88% vs the prior close of $1.14. Day range $1.13–$1.20, opened at $1.13.
- Volume was 23.60K shares, 0.1x its 50-day average of 222.70K — lighter than usual.
- Price is -47.6% vs its 50-day average ($2.16) and -67.8% vs its 200-day average ($3.51).
- 52-week range $1.13–$13.28; today's close sits at 0% of that range, 91.5% below the 52-week high.
- That makes 12 straight losses.
Oct 5, 2026 — LNAI slides 12.3% to $1.14, a 52-week low, 11 down days in a row
- Closed at $1.14, -12.31% vs the prior close of $1.30. Day range $1.14–$1.30, opened at $1.25.
- Volume was 69.00K shares, 0.3x its 50-day average of 221.58K — lighter than usual.
- Price is -47.7% vs its 50-day average ($2.18) and -67.8% vs its 200-day average ($3.54).
- 52-week range $1.14–$13.28; today's close sits at 0% of that range, 91.4% below the 52-week high.
- That makes 11 straight losses.
Oct 2, 2026 — LNAI slides 5.8% to $1.30, a 52-week low, 10 down days in a row
- Closed at $1.30, -5.80% vs the prior close of $1.38. Day range $1.23–$1.46, opened at $1.44.
- Volume was 124.90K shares, 0.6x its 50-day average of 219.69K — lighter than usual.
- Price is -41.0% vs its 50-day average ($2.20) and -63.7% vs its 200-day average ($3.58).
- 52-week range $1.21–$13.28; today's close sits at 1% of that range, 90.2% below the 52-week high.
- That makes 10 straight losses.
LNAI latest news & SEC filings
Every SEC filing by or about LNAI in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 13, 2026 · Form 10-K — Annual report
Annual report (audited full-year financial statements and business review)
Fiscal year ended Jun 30, 2026:
- Revenue: $51.99K
- Net income: -$3.56M (prior year -$178.01M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$1.06 (prior year -$86.27) (loss narrowed vs Jun 30, 2025)
Oct 9, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 29, 2026 · Form NT 10-K — Notice of late annual report
Notice of late annual report
Jul 17, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade LNAI
- How much it moves: over the last 20 sessions the average daily move was 7.01% (largest 17.6%). That is a volatile stock.
- Liquidity: about 101.09K shares (≈$68.78K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.68 vs a range of $0.66–$13.28 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:8 on May 22, 2026, 1:10 on Sep 30, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 10-K Oct 13, 2026; 8-K Oct 9, 2026; 8-K Jun 17, 2026.
- Share count: 5.03M shares outstanding (Oct 13, 2026), -78.5% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
LNAI market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.81 | 0.81 | 0.66 | 0.68 | 79.41K |
| Oct 15, 2026 | 0.87 | 0.92 | 0.82 | 0.83 | 37.80K |
| Oct 14, 2026 | 1.00 | 1.00 | 0.89 | 0.89 | 69.40K |
| Oct 13, 2026 | 1.09 | 1.09 | 1.01 | 1.03 | 46.00K |
| Oct 12, 2026 | 1.29 | 1.29 | 1.05 | 1.11 | 97.20K |
| Oct 9, 2026 | 1.17 | 1.68 | 0.88 | 1.23 | 853.30K |
| Oct 8, 2026 | 1.14 | 1.15 | 1.10 | 1.12 | 14.80K |
| Oct 7, 2026 | 1.19 | 1.19 | 1.08 | 1.09 | 20.00K |
| Oct 6, 2026 | 1.13 | 1.20 | 1.13 | 1.13 | 23.60K |
| Oct 5, 2026 | 1.25 | 1.30 | 1.14 | 1.14 | 69.00K |
| Oct 2, 2026 | 1.44 | 1.46 | 1.23 | 1.30 | 124.90K |
| Oct 1, 2026 | 1.54 | 1.60 | 1.38 | 1.38 | 38.20K |
| Sep 30, 2026 | 1.89 | 1.89 | 1.38 | 1.47 | 102.20K |
| Sep 29, 2026 | 1.91 | 1.95 | 1.75 | 1.77 | 54.10K |
| Sep 28, 2026 | 2.05 | 2.05 | 1.81 | 1.86 | 41.00K |
| Sep 25, 2026 | 2.00 | 2.20 | 1.90 | 1.93 | 28.90K |
| Sep 24, 2026 | 2.18 | 2.18 | 1.93 | 1.94 | 45.00K |
| Sep 23, 2026 | 2.30 | 2.37 | 2.10 | 2.14 | 51.80K |
| Sep 22, 2026 | 2.66 | 2.67 | 2.22 | 2.23 | 211.40K |
| Sep 21, 2026 | 2.39 | 2.43 | 2.23 | 2.30 | 13.70K |
About Lunai Bioworks
Lunai Bioworks (LNAI) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in SUITE 906 LOS ANGELES, CA. State of incorporation: DE. Fiscal year ends June 30. SEC CIK 1527728.
LNAI board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
LNAI financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Jun 30, 2026 | $51.99K | $-3.56M | -1.06 | $-5.29M |
| Jun 30, 2025 | — | $-178.01M | -86.27 | $-7.87M |
| Jun 30, 2024 | — | $-88.43M | -0.91 | $-10.97M |
| Jun 30, 2023 | — | $-39.68M | -0.71 | $-11.77M |
| Jun 30, 2022 | — | $-113.43M | -2.16 | $-15.73M |
Latest balance sheet: total assets $9.94M, total liabilities $18.97M, cash $1.71M (as of Jun 30, 2026).
LNAI earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on LNAI
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.